Short-term costs of preeclampsia to the United States health care system.
Warren Stevens,Tiffany Shih,Devin Incerti,Thanh G.N. Ton,Henry C. Lee,Desi Peneva,George A. Macones,Bahaeddine M Sibai,Anupam B. Jena +8 more
Reads0
Chats0
TLDR
In 2012, the cost of preeclampsia within the first 12 months of delivery was $2.18 billion in the United States ($1.03 billion for mothers and $1.15 billion for infants), and was disproportionately borne by births of low gestational age.About:
This article is published in American Journal of Obstetrics and Gynecology.The article was published on 2017-09-01 and is currently open access. It has received 183 citations till now. The article focuses on the topics: Population & Health care.read more
Citations
More filters
Journal ArticleDOI
Costs and Extra Length of Stay because of Neonatal Bloodstream Infection at a Teaching Hospital in Ghana
TL;DR: Neonatal BSI was significantly associated with prolonged LOS, and the continuous presence of experienced medical staff, as well as parents, to monitor newborns during their stay on the ward has enormous economic burden on both hospitals and caregivers.
Journal ArticleDOI
Who Is at Risk for Preeclampsia? Risk Factors for Developing Initial Preeclampsia in a Subsequent Pregnancy.
TL;DR: First pregnancy may serve as a window of opportunity to identify women at risk for future preeclampsia and other morbidities later in life, and complications in first pregnancy, including preterm delivery, perinatal mortality and gestational diabetes, are risk factors for primary preeclamping in second pregnancy.
Journal ArticleDOI
The prediction of preeclampsia: the way forward
TL;DR: The heterogeneity of preeclampsia has blighted efforts to predict early pregnancy early in gestation and has thwarted success in attempts at therapy with treatments, such as low-dose aspirin or global antioxidants as mentioned in this paper .
Journal ArticleDOI
Histopathological lesions and exposure to Plasmodium falciparum infections in the placenta increases the risk of preeclampsia among pregnant women
Dorotheah Obiri,Dorotheah Obiri,Isaac Joe Erskine,Daniel Oduro,Daniel Oduro,Daniel Oduro,Kwadwo A. Kusi,Kwadwo A. Kusi,Jones A. Amponsah,Ben Gyan,Kwame Adu-Bonsaffoh,Michael F. Ofori,Michael F. Ofori +12 more
TL;DR: It is suggested that placental histological changes and PM are independent risk factors for PE particularly in primigravida, and this findings might improve the management of PE in malaria-endemic regions.
Journal ArticleDOI
Current State of Preeclampsia Mouse Models: Approaches, Relevance, and Standardization.
TL;DR: A comprehensive review of mouse models that exhibit PE-like symptoms and a proposed standardization of physiological characteristics for analysis in murine models of PE is provided in this article, where the authors compare effects across models and find that many of these approaches have aspects that lack physiological relevance to this human disorder and may interfere with therapeutic development.
References
More filters
MonographDOI
Microeconometrics: Methods and Applications
TL;DR: This chapter discusses models for making pseudo-random draw, which combines asymptotic theory, Bayesian methods, and ML and NLS estimation with real-time data structures.
Journal ArticleDOI
WHO analysis of causes of maternal death: a systematic review
TL;DR: Haemorrhage and hypertensive disorders are major contributors to maternal deaths in developing countries and these data should inform evidence-based reproductive health-care policies and programmes at regional and national levels.
Journal ArticleDOI
Circulating Angiogenic Factors and the Risk of Preeclampsia
Richard J. Levine,Sharon Maynard,Cong Qian,Kee-Hak Lim,Lucinda England,Kai F. Yu,Enrique F. Schisterman,Ravi Thadhani,Benjamin P. Sachs,Franklin H. Epstein,Bahaeddine M Sibai,Vikas P. Sukhatme,S. Ananth Karumanchi +12 more
TL;DR: Alterations in the levels of sFlt-1 and free PlGF were greater in women with an earlier onset of preeclampsia and in women in whom preeClampsia was associated with a small-for-gestational-age infant.
Journal ArticleDOI
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.
Jürgen Rehm,Colin Mathers,Svetlana Popova,Svetlana Popova,Montarat Thavorncharoensap,Montarat Thavorncharoensap,Yot Teerawattananon,Jayadeep Patra +7 more
TL;DR: The burden of mortality and disease attributable to alcohol, both globally and for ten large countries, is quantified and concludes that alcohol consumption is one of the major avoidable risk factors, and actions to reduce burden and costs associated with alcohol should be urgently increased.
Related Papers (5)
Hypertension in pregnancy: Executive summary
James M. Roberts,Phyllis August,George Bakris,John R. Barton,Ira M. Bernstein,Maurice L. Druzin,Robert R. Gaiser,Joey P. Granger,Arun Jeyabalan,Donna D. Johnson,S. Ananth Karumanchi,Marshall D. Lindheimer,Michelle Y. Owens,Geroge R. Saade,Bahaeddine M Sibai,Catherine Y. Spong,Eleni Tsigas,Gerald E. Joseph,Nancy O'Reilly,Alyssa Politzer,Sarah Son,Karina Ngaiza +21 more
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Daniel L. Rolnik,David Wright,Liona C. Poon,Neil O'Gorman,Argyro Syngelaki,Catalina De Paco Matallana,Ranjit Akolekar,Simona Cicero,D. Janga,Mandeep Singh,Francisca S. Molina,Nicola Persico,Nicola Persico,Jacques Jani,Walter Plasencia,G. Papaioannou,Kinneret Tenenbaum-Gavish,Hamutal Meiri,Sveinbjörn Gizurarson,Kate Maclagan,Kypros H. Nicolaides +20 more